^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NeoTCR-P1

    i
    Other names: NeoTCR-P1, NeoTCR-P1 adoptive cell therapy, Autologous gene-edited TCR T cell product, Neoepitope specific adoptive T cell therapy, Neoantigen-targeted T cells therapy
    Associations
    News
    Trials
    Company:
    PACT Pharma
    Drug class:
    TCR modulator, T lymphocyte replacement
    Related drugs:
    Associations
    News
    Trials